Literature DB >> 2548434

Histochemically demonstrable phosphotyrosyl-protein phosphatase in normal human breast, in benign breast diseases and in breast cancer.

S Partanen1, F Pekonen.   

Abstract

The activity of phosphotyrosyl-protein phosphatase enzyme was investigated by a histochemical method in the normal human breast and in breast diseases in order to evaluate its possible significance in the genesis and in the growth of benign and malignant epithelial proliferative. In normal human breast tissue only a weak enzyme activity was present. The activity was elevated in benign disease in actively proliferative lesions and in 71% of the cases of breast cancers. When enzyme activity of breast cancers was compared with the content of receptors for epidermal growth factor and insulin-like growth factor-I, no association was found. It is concluded that phosphotyrosyl-protein phosphatase is increased in actively proliferating human breast diseases. Thus the putative increase in phosphotyrosyl-proteins mediating benign and malignant epithelial proliferations is rather caused by an increase in protein-tyrosine kinase activity than by a decrease in phosphotyrosyl-protein phosphatase activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548434

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer.

Authors:  A E Ottenhoff-Kalff; B A van Oirschot; A Hennipman; R A de Weger; G E Staal; G Rijksen
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

2.  MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1.

Authors:  Yanlong Wang; Jiyu Yang; Pangtao Chen; Yu Song; Weizheng An; Haoran Zhang; Butegeleqi Butegeleqi; Jinglong Yan
Journal:  Cancer Med       Date:  2020-02-17       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.